Measures for the Administration of Drug Recall

On October 26, the National medical product administration issued the newly revised Measures for the Administration of Drug Recall, which will come into force as of November 1. The new version of the Measures improves the handling measures for recalled drugs and clarifies the responsibilities of drug marketing license holders. The new version of the Measures has improved the holder’s requirements for the investigation and evaluation of drugs that may have quality problems or other potential safety hazards, refined the implementation procedures for the holder’s voluntary recall, and urged and guided the holder to actively recall drugs with quality problemsRead More →

Thank you for your interests/registration! For complete and full access to our platform, please contact us to subscribe as a paid-up member. The annual fee is $5,500 Best! Paolo yue Email: yuefeng7832@hotmail.com Cell: 008613501397114

Existing Users Log In
   
New User Registration
*Required field